Pharmazz, Inc.: Clinical Trials

14 trials sponsored by Pharmazz, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 recruiting, 3 not yet recruiting, 1 active not recruiting. 6 Phase 2, 5 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Recruiting 2, Not yet recruiting 1
Phase 35Completed 2, Not yet recruiting 2, Recruiting 1
Phase 42Active not recruiting 1, Recruiting 1
Phase 11Completed 1

Follow Pharmazz, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Normal Saline, Centhaquine - Acute Respiratory Distress Syndrome (ARDS)
Phase 2Not yet recruitingPharmazz, Inc.802027-05-012026-09-17
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Normal Saline, Centhaquine - Hypovolemic Shock
Phase 3Not yet recruitingPharmazz, Inc.4302027-02-012026-09-17
Sovateltide for the Treatment of Acute Traumatic Brain Injury
Placebo, Sovateltide - Traumatic Brain Injury
Phase 3Not yet recruitingPharmazz, Inc.2142026-12-012026-10-13
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Drug: Normal Saline, Sovateltide - Acute Ischemic Stroke, Cerebral Stroke
Phase 3RecruitingPharmazz, Inc.5142025-07-242026-09-15
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Sovateltide, Normal Saline - Acute Cerebral Ischemia
Phase 4Active not recruitingPharmazz, Inc.1602024-01-082026-09-29
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Normal Saline along with standard treatment, Sovateltide along with standard treatment - Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia
Phase 2RecruitingPharmazz, Inc.402023-09-062025-12-31
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Centhaquine - Hypovolemic Shock
Phase 4RecruitingPharmazz, Inc.4002021-08-132026-09-17
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard treatment - Cerebral Ischemia, Cerebral Infarction
Phase 3CompletedPharmazz, Inc.1582019-11-102023-10-18
Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
Normal saline + Standard Treatment, Centhaquine + Standard Treatment - Hypovolemic Shock
Phase 3CompletedPharmazz, Inc.1052019-01-312019-10-04
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Spinal Cord Injury
Phase 2RecruitingPharmazz, Inc.402019-01-102025-07-04
PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease
Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard treatment - Alzheimer Disease, Dementia
Phase 2CompletedPharmazz, Inc.802018-03-232023-01-12
PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Stroke, Cerebral Ischemia
Phase 2CompletedPharmazz, Inc.402018-01-192025-05-12
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Normal Saline, Centhaquine - Hypovolemic Shock, Blood Loss
Phase 2CompletedPharmazz, Inc.502017-05-292019-08-14
A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers
PMZ-2010 (Centhaquin) - Healthy
Phase 1CompletedPharmazz, Inc.242014-10-012015-04-28

Conditions studied

Shock (4)  ·  Stroke (4)  ·  Brain Ischemia (2)  ·  Hemorrhage (2)  ·  Alzheimer Disease (1)  ·  Asphyxia Neonatorum (1)  ·  Brain Injuries, Traumatic (1)  ·  Cerebral Infarction (1)  ·  Dementia (1)  ·  Hypovolemia (1)  ·  Hypoxia (1)  ·  Hypoxia-Ischemia, Brain (1)  ·  Ischemia (1)  ·  Ischemic Stroke (1)  ·  Respiratory Distress Syndrome (1)

Interventions

Saline Solution (7)  ·  sovateltide (7)  ·  centhaquine (6)

Countries

India (10)  ·  Germany (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Anil Gulati (5)  ·  Anil Gulati, MD, PhD (3)  ·  Manish Lavhale, Ph.D. (2)  ·  Ashish O Goyal, MD (1)

Results publications

PMID 33428177, PMID 33173916, PMID 33970455, PMID 34061314, PMID 38999331, PMID 39542995